Dr Haider Al-Janabi
Clinical Medicine, School of Medicine and Population Health
Postdoctoral Research Associate
h.h.al-janabi@sheffield.ac.uk
+44 114 215 9209
+44 114 215 9209
The Medical School
Full contact details
Dr Haider Al-Janabi
Clinical Medicine, School of Medicine and Population Health
The Medical School
Beech Hill Road
Sheffield
S10 2RX
Clinical Medicine, School of Medicine and Population Health
The Medical School
Beech Hill Road
Sheffield
S10 2RX
- Publications
-
Journal articles
- Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy. Journal for ImmunoTherapy of Cancer, 12(7), e009368-e009368.
- Nanobugs as drugs: bacterial derived nanomagnets enhance tumor targeting and oncolytic activity of HSV‐1 virus. Small, 18(13). View this article in WRRO
- Macrophage Regulation of the Development of Castration-Resistant Prostate Cancer. Cancer Research, 81(21), 5399-5400.
- Macrophages Mediate the Antitumor Effects of the Oncolytic Virus HSV1716 in Mammary Tumors. Molecular Cancer Therapeutics, 20(3), 589-601.
Conference proceedings papers
- Abstract LB-188: Breast cancer immunotherapy using magnetized HSV1716. Cancer Research, Vol. 79(13_Supplement)
Other
- Data from Macrophages Mediate the Antitumor Effects of the Oncolytic Virus HSV1716 in Mammary Tumors.
- Data from Macrophages Mediate the Antitumor Effects of the Oncolytic Virus HSV1716 in Mammary Tumors.
- Supplementary Data from Macrophages Mediate the Antitumor Effects of the Oncolytic Virus HSV1716 in Mammary Tumors.
- Supplementary Data from Macrophages Mediate the Antitumor Effects of the Oncolytic Virus HSV1716 in Mammary Tumors.